Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Invo Bioscience Inc (INVO)

Invo Bioscience Inc (INVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,851
  • Shares Outstanding, K 10,469
  • Annual Sales, $ 1,040 K
  • Annual Income, $ -8,350 K
  • 60-Month Beta -1.15
  • Price/Sales 35.44
  • Price/Cash Flow N/A
  • Price/Book 9.27
Trade INVO with:

Options Overview

Details
  • Implied Volatility 102.40%
  • Historical Volatility 30.10%
  • IV Percentile 38%
  • IV Rank 41.16%
  • IV High 212.56% on 08/26/21
  • IV Low 25.35% on 08/27/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.20
  • Number of Estimates 2
  • High Estimate -0.18
  • Low Estimate -0.22
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.39 +2.52%
on 09/09/21
4.24 -18.02%
on 08/17/21
-0.77 (-18.21%)
since 08/16/21
3-Month
3.39 +2.52%
on 09/09/21
5.00 -30.48%
on 06/29/21
-0.92 (-21.00%)
since 06/16/21
52-Week
2.90 +19.86%
on 01/07/21
12.30 -71.74%
on 03/09/21
-1.22 (-26.04%)
since 09/16/20

Most Recent Stories

More News
INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada

/PRNewswire/ -- (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, an affordable and effective infertility treatment, announced...

INVO : 3.48 (-1.25%)
INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta

and , /PRNewswire/ --, a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, announced today as the official opening for the Company's second INVO...

INVO : 3.48 (-1.25%)
Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference

/PRNewswire/ -- (NASDAQ: INVO)a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, announced today that Dr. will be presenting at the Association...

INVO : 3.48 (-1.25%)
Invo BioScience Inc. (INVO) Reports Q2 Loss, Lags Revenue Estimates

Invo BioScience Inc. (INVO) delivered earnings and revenue surprises of 10.53% and -0.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

INVO : 3.48 (-1.25%)
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's...

INVO : 3.48 (-1.25%)
INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

/PRNewswire/ -- , a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility,...

INVO : 3.48 (-1.25%)
Invo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Invo BioScience Inc. (INVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INVO : 3.48 (-1.25%)
INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama

/PRNewswire/ --(NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today announced the Company's first Joint Venture INVO Center...

INVO : 3.48 (-1.25%)
INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration

/PRNewswire/ -- (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed...

INVO : 3.48 (-1.25%)
INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta

and , /PRNewswire/ -- a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility,...

INVO : 3.48 (-1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility...

See More

Key Turning Points

3rd Resistance Point 3.69
2nd Resistance Point 3.65
1st Resistance Point 3.58
Last Price 3.48
1st Support Level 3.48
2nd Support Level 3.44
3rd Support Level 3.37

See More

52-Week High 12.30
Fibonacci 61.8% 8.71
Fibonacci 50% 7.60
Fibonacci 38.2% 6.49
Last Price 3.48
52-Week Low 2.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar